Sanofi imaging cancer drug 'sensors'
Sanofi-Aventis is using the latest targeted imaging techniques to assess how its cancer drugs affect organisms at the molecular level.
Archives for September 23, 2007
Merck's HIV vaccine steps out of development
Merck & Co. has stopped the Phase II trial of its V520 HIV vaccine after interim results showed that the vaccine was not effective and did not prevent infection.
SolVin to increase PVDC production
SolVin is to expand its polyvinylidene chloride (PVDC) latex manufacturing site in Tavaux, France, in a bid to meet growing demand for the packaging material.
Bespak for sale?
UK-based Bespak, one of the two contract manufacturers of Pfizer's inhaled insulin Exubera, confirmed on Friday it has been approached by a potential buyer.
DSM takes on purification tech
Netherlands-based DSM has invested an undisclosed sum in Danish purification technology company Upfront Chromatography to boost its protein separation business.
Pfizer to spin off Japan drug research lab
Pfizer is considering offers from investors in a bid to spin off its drug research and development laboratory in Japan and make it an independent entity, according to media reports.